Cargando…
Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study
OBJECTIVES: The aim of this prospective, randomized, double-blind, controlled clinical study was to evaluate the analgesic effect of ibuprofen versus diclofenac plus orphenadrine on postoperative pain in orthognathic surgery. MATERIAL AND METHODS: Patients who underwent orthognathic surgery were ran...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072507/ https://www.ncbi.nlm.nih.gov/pubmed/35103836 http://dx.doi.org/10.1007/s00784-022-04381-5 |
_version_ | 1784701077117992960 |
---|---|
author | Tomic, Josip Wallner, Jürgen Mischak, Irene Sendlhofer, Gerald Zemann, Wolfgang Schanbacher, Monika Hassanzadeh, Hamid Sandner-Kiesling, Andreas Payer, Michael Zrnc, Tomislav A. |
author_facet | Tomic, Josip Wallner, Jürgen Mischak, Irene Sendlhofer, Gerald Zemann, Wolfgang Schanbacher, Monika Hassanzadeh, Hamid Sandner-Kiesling, Andreas Payer, Michael Zrnc, Tomislav A. |
author_sort | Tomic, Josip |
collection | PubMed |
description | OBJECTIVES: The aim of this prospective, randomized, double-blind, controlled clinical study was to evaluate the analgesic effect of ibuprofen versus diclofenac plus orphenadrine on postoperative pain in orthognathic surgery. MATERIAL AND METHODS: Patients who underwent orthognathic surgery were randomized into two groups to receive intravenously either 600 mg of ibuprofen (I-group) or 75 mg diclofenac plus 30 mg orphenadrine (D-group), both of which were given twice daily. Additionally, both groups were given metamizole 500 mg. Rescue pain medication consisted of acetaminophen 1000 mg and piritramide 7.5 mg as needed. To assess the pain intensity, the primary end point was the numeric rating scale (NRS) recorded over the course of the hospital stay three times daily for 3 days. RESULTS: One hundred nine patients were enrolled (age range, 18 to 61 years) between May 2019 and November 2020. Forty-eight bilateral sagittal split osteotomies (BSSO) and 51 bimaxillary osteotomies (BIMAX) were performed. Surgical subgroup analysis found a significant higher mean NRS (2.73 vs.1.23) in the BIMAX D-group vs. I-group (p = 0.015) on the third postoperative day. Additionally, as the patient’s body mass index (BMI) increased, the mean NRS (r = 0.517, p = 0.001) also increased. No differences were found between age, gender, length of hospital stay, weight, operating times, number of patients with complete pain relief, acetaminophen or piritramide intake, and NRS values. No adverse events were observed. CONCLUSION: The results of this study demonstrate that ibuprofen administration and lower BMI were associated with less pain for patients who underwent bimaxillary osteotomy on the third postoperative day. Therefore, surgeons may prefer ibuprofen for more effective pain relief after orthognathic surgery. CLINICAL RELEVANCE: Ibuprofen differs from diclofenac plus orphenadrine in class and is a powerful analgetic after orthognathic surgery. |
format | Online Article Text |
id | pubmed-9072507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-90725072022-05-07 Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study Tomic, Josip Wallner, Jürgen Mischak, Irene Sendlhofer, Gerald Zemann, Wolfgang Schanbacher, Monika Hassanzadeh, Hamid Sandner-Kiesling, Andreas Payer, Michael Zrnc, Tomislav A. Clin Oral Investig Original Article OBJECTIVES: The aim of this prospective, randomized, double-blind, controlled clinical study was to evaluate the analgesic effect of ibuprofen versus diclofenac plus orphenadrine on postoperative pain in orthognathic surgery. MATERIAL AND METHODS: Patients who underwent orthognathic surgery were randomized into two groups to receive intravenously either 600 mg of ibuprofen (I-group) or 75 mg diclofenac plus 30 mg orphenadrine (D-group), both of which were given twice daily. Additionally, both groups were given metamizole 500 mg. Rescue pain medication consisted of acetaminophen 1000 mg and piritramide 7.5 mg as needed. To assess the pain intensity, the primary end point was the numeric rating scale (NRS) recorded over the course of the hospital stay three times daily for 3 days. RESULTS: One hundred nine patients were enrolled (age range, 18 to 61 years) between May 2019 and November 2020. Forty-eight bilateral sagittal split osteotomies (BSSO) and 51 bimaxillary osteotomies (BIMAX) were performed. Surgical subgroup analysis found a significant higher mean NRS (2.73 vs.1.23) in the BIMAX D-group vs. I-group (p = 0.015) on the third postoperative day. Additionally, as the patient’s body mass index (BMI) increased, the mean NRS (r = 0.517, p = 0.001) also increased. No differences were found between age, gender, length of hospital stay, weight, operating times, number of patients with complete pain relief, acetaminophen or piritramide intake, and NRS values. No adverse events were observed. CONCLUSION: The results of this study demonstrate that ibuprofen administration and lower BMI were associated with less pain for patients who underwent bimaxillary osteotomy on the third postoperative day. Therefore, surgeons may prefer ibuprofen for more effective pain relief after orthognathic surgery. CLINICAL RELEVANCE: Ibuprofen differs from diclofenac plus orphenadrine in class and is a powerful analgetic after orthognathic surgery. Springer Berlin Heidelberg 2022-02-01 2022 /pmc/articles/PMC9072507/ /pubmed/35103836 http://dx.doi.org/10.1007/s00784-022-04381-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Tomic, Josip Wallner, Jürgen Mischak, Irene Sendlhofer, Gerald Zemann, Wolfgang Schanbacher, Monika Hassanzadeh, Hamid Sandner-Kiesling, Andreas Payer, Michael Zrnc, Tomislav A. Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title | Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title_full | Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title_fullStr | Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title_full_unstemmed | Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title_short | Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
title_sort | intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072507/ https://www.ncbi.nlm.nih.gov/pubmed/35103836 http://dx.doi.org/10.1007/s00784-022-04381-5 |
work_keys_str_mv | AT tomicjosip intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT wallnerjurgen intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT mischakirene intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT sendlhofergerald intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT zemannwolfgang intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT schanbachermonika intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT hassanzadehhamid intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT sandnerkieslingandreas intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT payermichael intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy AT zrnctomislava intravenousibuprofenversusdiclofenacplusorphenadrineinorthognathicsurgeryaprospectiverandomizeddoubleblindcontrolledclinicalstudy |